Viatris (VTRS) Capital Expenditures (2020 - 2026)

Viatris' (VTRS) quarterly Capital Expenditures came in at $39.9 million in Q1 2026, down 6.34% year-on-year from $42.6 million in Q1 2025, and down 79.69% quarter-over-quarter from $196.5 million in Q4 2025.

Viatris (VTRS) Capital Expenditures (2020 - 2026) Analysis & Trends

Viatris' Capital Expenditures history runs 7 years deep, the most recent figure standing at $39.9 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 6.34% year-over-year to $39.9 million in Q1 2026; TTM through Mar 2026 was $376.1 million, a 17.97% increase from a year earlier, with the FY2025 full-year figure at $378.8 million, up 16.2% from the prior year.
  • Capital Expenditures declined to $39.9 million in Q1 2026 per VTRS's latest filing, from $196.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $196.5 million in Q4 2025 and bottomed at $39.9 million in Q1 2026.
  • The 5-year median for Capital Expenditures is $77.0 million (2024), against an average of $89.9 million.
  • Across the five-year window, Capital Expenditures slipped 25.89% in 2023 and jumped 39.96% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at $153.7 million in 2022, then advanced by 7.68% to $165.5 million in 2023, then fell by 15.17% to $140.4 million in 2024, then surged by 39.96% to $196.5 million in 2025, then plunged by 79.69% to $39.9 million in 2026.
  • Per Business Quant, the three latest VTRS Capital Expenditures figures stand at $39.9 million (Q1 2026), $196.5 million (Q4 2025), and $86.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 10.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.90 Mn
Mar 31, 2026 39.90 Mn
Dec 31, 2025 196.50 Mn
Dec 31, 2025 196.50 Mn
Sep 30, 2025 86.80 Mn
Sep 30, 2025 86.80 Mn
Jun 30, 2025 52.90 Mn
Jun 30, 2025 52.90 Mn
Mar 31, 2025 42.60 Mn
Mar 31, 2025 42.60 Mn
Dec 31, 2024 140.40 Mn
Dec 31, 2024 140.40 Mn
Sep 30, 2024 77.00 Mn
Sep 30, 2024 77.00 Mn
Jun 30, 2024 58.80 Mn
Jun 30, 2024 58.80 Mn
Mar 31, 2024 49.80 Mn
Mar 31, 2024 49.80 Mn
Dec 31, 2023 165.50 Mn
Dec 31, 2023 165.50 Mn